Can kidney parenchyma metabolites serve as prognostic biomarkers for long-term kidney function after nephrectomy for renal cell carcinoma? A preliminary study.

Publication Year: 2020

DOI:
10.1093/ckj/sfaa185

PMCID:
PMC8894921

PMID:
35261758

Journal Information

Full Title: Clin Kidney J

Abbreviation: Clin Kidney J

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Urology & Nephrology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST STATEMENT Dr E.A.J. reports other financial activities outside the submitted work as Chief Medical Officer and Stockholder at Goldilocks Therapeutics, Inc. All other authors declare no COI."

Evidence found in paper:

"FUNDING This research was supported by the CKD Biomarkers Consortium Pilot and Feasibility Studies Program, The BioCon Scientific Data Coordinating Center, funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK: U01 DK103225) and NIH Center Grant P30 CA008748."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025